help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tozzo, E.
Right arrow Articles by Kahn, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tozzo, E.
Right arrow Articles by Kahn, B. B.
Endocrinology Vol. 138, No. 4 1604-1611
Copyright © 1997 by The Endocrine Society


ARTICLES

Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter1

Effie Tozzo, Luigi Gnudi and Barbara B. Kahn

Division of Endocrinology and Metabolism, Department of Medicine at Harvard Medical School and Beth Israel Hospital, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Barbara B. Kahn, M.D., Diabetes Unit, Beth Israel Hospital, 330 Brookline Avenue, Boston, Massachusetts 02215. E-mail: bkahn{at}bidmc.harvard.edu

In diabetic rodents and humans, glucose transporter 4 (GLUT4) expression is suppressed in adipocytes in association with insulin resistance. Transgenic mice overexpressing GLUT4 selectively in fat have enhanced glucose disposal in vivo and massively increased glucose transport in adipocytes. To determine whether overexpression can be maintained in diabetes and whether it can prevent insulin resistance, we rendered wild-type and transgenic mice diabetic with streptozotocin. After 12–14 days, blood glucose was more than 21.4 mM and plasma insulin was 1.06 ng/ml or less in both diabetic groups in the fed state. Body weight was reduced and gonadal fat pad weight and adipocyte size were 52–75% smaller in both nontransgenic and transgenic diabetic mice, compared with nondiabetic. Basal and maximally-stimulated rates of lipolysis were similar in adipocytes from nontransgenic and transgenic mice, but the ED50 for isoproterenol stimulation was 50% lower in transgenic mice. There was no difference in the sensitivity to insulin to inhibit lipolysis. In adipocytes of nontransgenic diabetic mice, GLUT4 protein was reduced 34%, with a 46% reduction in insulin stimulated glucose transport. In contrast, in adipocytes of transgenic diabetic mice, GLUT4 remained 21-fold overexpressed, resulting in 21-fold increased basal and 10-fold increased insulin stimulated glucose transport. Injection of insulin (0.7 mU/g BW) resulted in a 35% decrease in blood glucose in transgenic diabetic mice (P < 0.05), with no effect in nontransgenic diabetic mice. Thus, high-level overexpression of GLUT4 driven by a fat specific promoter can be maintained with insulinopenic diabetes, even when fat cell metabolism is markedly altered. Overexpression of GLUT4 in adipocytes prevents insulin resistant glucose transport at the cellular level and improves insulin action in vivo, even with overt diabetes.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
V. Puri, A. Chakladar, J. V. Virbasius, S. Konda, A. M. Powelka, M. Chouinard, G. N. Hagan, R. Perugini, and M. P. Czech
RNAi-based gene silencing in primary mouse and human adipose tissues
J. Lipid Res., February 1, 2007; 48(2): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Knauf, J. Rieusset, M. Foretz, P. D. Cani, M. Uldry, M. Hosokawa, E. Martinez, M. Bringart, A. Waget, S. Kersten, et al.
Peroxisome Proliferator-Activated Receptor-{alpha}-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain
Endocrinology, September 1, 2006; 147(9): 4067 - 4078.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Viswanadha and C. Londos
Optimized conditions for measuring lipolysis in murine primary adipocytes
J. Lipid Res., August 1, 2006; 47(8): 1859 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Corporeau, C. L. Foll, M. Taouis, J.-P. Gouygou, J.-P. Berge, and J. Delarue
Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E78 - E86.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Kurlawalla-Martinez, B. Stiles, Y. Wang, S. U. Devaskar, B. B. Kahn, and H. Wu
Insulin Hypersensitivity and Resistance to Streptozotocin-Induced Diabetes in Mice Lacking PTEN in Adipose Tissue
Mol. Cell. Biol., March 15, 2005; 25(6): 2498 - 2510.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Jimenez-Chillaron, M. Hernandez-Valencia, C. Reamer, S. Fisher, A. Joszi, M. Hirshman, A. Oge, S. Walrond, R. Przybyla, C. Boozer, et al.
{beta}-Cell Secretory Dysfunction in the Pathogenesis of Low Birth Weight-Associated Diabetes: A Murine Model
Diabetes, March 1, 2005; 54(3): 702 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Mitra, X. Zheng, and M. P. Czech
RNAi-based Analysis of CAP, Cbl, and CrkII Function in the Regulation of GLUT4 by Insulin
J. Biol. Chem., September 3, 2004; 279(36): 37431 - 37435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bluher, M.-E. Patti, S. Gesta, B. B. Kahn, and C. R. Kahn
Intrinsic Heterogeneity in Adipose Tissue of Fat-specific Insulin Receptor Knock-out Mice Is Associated with Differences in Patterns of Gene Expression
J. Biol. Chem., July 23, 2004; 279(30): 31891 - 31901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. C. Connolly, L. N. Aglione, M. S. Smith, D. B. Lacy, and M. C. Moore
Insulin action during late pregnancy in the conscious dog
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E909 - E915.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Perez, C. Fernandez-Galaz, T. Fernandez-Agullo, C. Arribas, A. Andres, M. Ros, and J. M. Carrascosa
Leptin Impairs Insulin Signaling in Rat Adipocytes
Diabetes, February 1, 2004; 53(2): 347 - 353.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
D. Chen, F. Mauvais-Jarvis, M. Bluher, S. J. Fisher, A. Jozsi, L. J. Goodyear, K. Ueki, and C. R. Kahn
p50{alpha}/p55{alpha} Phosphoinositide 3-Kinase Knockout Mice Exhibit Enhanced Insulin Sensitivity
Mol. Cell. Biol., January 1, 2004; 24(1): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. B. Knight, C. A. Eyster, B. A. Griesel, and A. L. Olson
Regulation of the human GLUT4 gene promoter: Interaction between a transcriptional activator and myocyte enhancer factor 2A
PNAS, December 9, 2003; 100(25): 14725 - 14730.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. A. Laffitte, L. C. Chao, J. Li, R. Walczak, S. Hummasti, S. B. Joseph, A. Castrillo, D. C. Wilpitz, D. J. Mangelsdorf, J. L. Collins, et al.
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
PNAS, April 29, 2003; 100(9): 5419 - 5424.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Konrad, P. J. Bilan, Z. Nawaz, G. Sweeney, W. Niu, Z. Liu, C. N. Antonescu, A. Rudich, and A. Klip
Need for GLUT4 Activation to Reach Maximum Effect of Insulin-Mediated Glucose Uptake in Brown Adipocytes Isolated From GLUT4myc-Expressing Mice
Diabetes, September 1, 2002; 51(9): 2719 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. S. Surwit, T. M. Dixon, A. E. Petro, K. W. Daniel, and S. Collins
Diazoxide Restores {beta}3-Adrenergic Receptor Function in Diet-Induced Obesity and Diabetes
Endocrinology, October 1, 2000; 141(10): 3630 - 3637.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. D. Klaman, O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M. Zabolotny, N. Moghal, M. Lubkin, Y.-B. Kim, A. H. Sharpe, et al.
Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
Mol. Cell. Biol., August 1, 2000; 20(15): 5479 - 5489.
[Abstract] [Full Text]


Home page
NEJMHome page
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. R. Coe, M. A. Simpson, and D. A. Bernlohr
Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels
J. Lipid Res., May 1, 1999; 40(5): 967 - 972.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. V. Thai, S. Guruswamy, K. T. Cao, J. E. Pessin, and A. L. Olson
Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required for GLUT4 Gene Expression in Transgenic Mice. REGULATION OF MEF2 DNA BINDING ACTIVITY IN INSULIN-DEFICIENT DIABETES
J. Biol. Chem., June 5, 1998; 273(23): 14285 - 14292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Oshel, J. B. Knight, K. T. Cao, M. V. Thai, and A. L. Olson
Identification of a 30-Base Pair Regulatory Element and Novel DNA Binding Protein That Regulates the Human GLUT4 Promoter in Transgenic Mice
J. Biol. Chem., July 28, 2000; 275(31): 23666 - 23673.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society